Drug Discovery Targeting Drug Resistant Bacteria Book

Drug Discovery Targeting Drug Resistant Bacteria

  • Author : Prashant Kesharwani
  • Publisher : Academic Press
  • Release Date : 2020-05-15
  • Genre: Business & Economics
  • Pages : 432
  • ISBN 10 : 9780128184813

Drug Discovery Targeting Drug Resistant Bacteria Excerpt :

Drug Discovery Targeting Drug-Resistant Bacteria explores the status and possible future of developments in fighting drug-resistant bacteria. The book covers the majority of microbial diseases and the drugs targeting them. In addition, it discusses the potential targeting strategies and innovative approaches to address drug resistance. It brings together academic and industrial experts working on discovering and developing drugs targeting drug-resistant (DR) bacterial pathogens. New drugs active against drug-resistant pathogens are discussed, along with new strategies being used to discover molecules acting via new modes of action. In addition, alternative therapies such as peptides and phages are included. Pharmaceutical scientists, microbiologists, medical professionals, pathologists, researchers in the field of drug discovery, infectious diseases and microbial drug discovery both in academia and in industrial settings will find this book helpful. Written by scientists with extensive industrial experience in drug discovery Provides a balanced view of the field, including its challenges and future directions Includes a special chapter on the identification and development of drugs against pathogens which exhibit the potential to be used as weapons of war

Sustainable Agriculture Reviews 46 Book

Sustainable Agriculture Reviews 46

  • Author : Harsh Panwar
  • Publisher : Springer Nature
  • Release Date : 2020-09-29
  • Genre: Technology & Engineering
  • Pages : 231
  • ISBN 10 : 9783030530242

Sustainable Agriculture Reviews 46 Excerpt :

According to the World Health Organization, antimicrobial resistance is a major threat to global health because the number of alternative antibiotics is very limited. Antimicrobial resistance is a slow evolutionary process that has been accelerated by human activities in health, environment and agriculture sectors. Due to their wide application, antibiotics and their residues have been found in almost all food products and natural ecosystems. This book reviews the drivers, impact and mitigation of antimicrobial resistance, with focus on methods and targets.

Antibiotic Drug Discovery Book

Antibiotic Drug Discovery

  • Author : Steven M Firestine
  • Publisher : Royal Society of Chemistry
  • Release Date : 2017-05-19
  • Genre: Medical
  • Pages : 271
  • ISBN 10 : 9781788011495

Antibiotic Drug Discovery Excerpt :

Recent years have seen a resurgence of antibiotic drug discovery. This book brings together the relevant information to assess the state-of-the-art. It identifies and elaborates the most recent and compelling strategies for antibiotic drug discovery with a primary focus on new targets, mechanisms and molecular entities. Addressing the need for continued investment in antibiotic drug development, the book provides a point of reference for the rapidly expanding infectious disease research community. In addition to its attention on new targets, the book focusses on the medicinal chemistry and chemistry of the targets. Within this framework, chapters from leading researchers in academia and industry address findings in important areas such as biofilm production, narrow spectrum antibiotics and novel antibacterials from previously uncultured soil bacteria. This book will be a useful resource for postgraduate students and researchers in medicinal chemistry wishing to understand the latest approaches to antibiotic drug discovery.

Antimicrobial Drug Discovery Book

Antimicrobial Drug Discovery

  • Author : G. Tegos
  • Publisher : CABI
  • Release Date : 2012
  • Genre: Anti-infective agents
  • Pages : 369
  • ISBN 10 : 1780640315

Antimicrobial Drug Discovery Excerpt :

Drug resistance is increasing among a variety of human pathogenic microorganisms such as Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumaniii, Pseudomonas aeruginosa and Enterobacter spp. (currently dubbed the 'ESKAPE' pathogens), and has emerged as one of the most important clinical challenges of this century. Increased general awareness and fear of these pathogens means there is a growing demand for research to tackle the threat of multidrug resistance. Documenting the latest research in the field, this book discusses current and promising activities to discover new antimicrobials in five key areas: molecular genetics and systems microbiology; synthetic, computational chemistry and chemoinformatics; High Throughput Screening (HTS); non-vertebrate model hosts; and light- and nano-based technologies.

Combination Therapy Against Multidrug Resistance Book

Combination Therapy Against Multidrug Resistance

  • Author : Mohmmad Younus Wani
  • Publisher : Academic Press
  • Release Date : 2020-04-30
  • Genre: Business & Economics
  • Pages : 268
  • ISBN 10 : 9780128205785

Combination Therapy Against Multidrug Resistance Excerpt :

Combination Therapy against Multidrug Resistance explores the potential of combination therapy as an efficient strategy to combat multi-drug resistance. Multidrug resistance (MDR) occurs when microorganisms such as bacteria, fungi, viruses, and parasites are excessively exposed to antimicrobial drugs such as antibiotics, antifungals, or antivirals, and in response the microorganism undergoes mutations or develops different resistance mechanisms to combat the drug for its survival. MDR is becoming an increasingly serious problem in both developed and developing nations. Bacterial resistance to antibiotics has developed faster than the production of new antibiotics, making bacterial infections increasingly difficult to treat, and the same is true for a variety of other diseases. Combination therapy proves to be a promising strategy as it offers potential benefits such as a broad spectrum of efficacy, greater potency than the drugs used in monotherapy, improved safety and tolerability, and reduction in the number of resistant organisms. This book considers how combination therapy can be applied in multiple situations, including cancer, HIV, tuberculosis, fungal infections, and more. Combination Therapy Against Multidrug Resistance gathers the most relevant information on the prospects of combination therapy as a strategy to combat multridrug resistance and helping to motivate the industrial sector and government agencies to invest more in research and development of this strategy as a weapon to tackle the multidrug resistance problem. It will be useful to academics and researchers involved in the development of new antimicrobial or antiinfective agents and treatment strtategies to combat multidrug resistance. Clinicians and medical nurses working in the field of infection prevention and control (IPC) will also find the book relevant Explores strategic methods with investigation of both short- and long-term goals to combat multidrug resistance Presents a broad scope to

Frontiers in Anti Infective Drug Discovery Book

Frontiers in Anti Infective Drug Discovery

  • Author : Atta-ur-Rahman
  • Publisher : Bentham Science Publishers
  • Release Date : 2015-06-30
  • Genre: Medical
  • Pages : 246
  • ISBN 10 : 9781681080826

Frontiers in Anti Infective Drug Discovery Excerpt :

This eBook series brings updated reviews to readers interested in advances in the development of anti-infective drug design and discovery. The scope of the eBook series covers a range of topics including rational drug design and drug discovery, medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, recent important patents, and structure-activity relationships. Frontiers in Anti-Infective Drug Discovery is a valuable resource for pharmaceutical scientists and post-graduate students seeking updated and critically important information for developing clinical trials and devising research plans in this field. The fourth volume of this series features 5 chapters that cover the following topics: - An overview of the incidence of neuraminadase resistance in influenza viruses in the Americas from 2004 to 2014 - Phenothiazines and derivative compounds for treating Trypanosoma cruzi infections - New antibacterial drug targets such as polysaccharide deacetylases - Improvements in aminoglycoside synthesis and biological activity (including RNA targeting) - A review of new chemotherapeutic agents against common infections.

Challenges to Tackling Antimicrobial Resistance Economic and Policy Responses Book

Challenges to Tackling Antimicrobial Resistance Economic and Policy Responses

  • Author : OECD
  • Publisher : OECD Publishing
  • Release Date : 2020-04-01
  • Genre: Uncategoriezed
  • Pages : 250
  • ISBN 10 : 9781108864121

Challenges to Tackling Antimicrobial Resistance Economic and Policy Responses Excerpt :

Antimicrobial resistance (AMR) is a biological mechanism whereby a microorganism evolves over time to develop the ability to become resistant to antimicrobial therapies such as antibiotics. The drivers of and potential solutions to AMR are complex, often spanning multiple sectors. The internationally recognized response to AMR advocates for a ‘One Health’ approach, which requires policies to be developed and implemented across human, animal, and environmental health.

Drug Discovery and Development Book

Drug Discovery and Development

  • Author : Omboon Vallisuta
  • Publisher : BoD – Books on Demand
  • Release Date : 2015-06-03
  • Genre: Medical
  • Pages : 332
  • ISBN 10 : 9789535121282

Drug Discovery and Development Excerpt :

It is very important for scientists all over the globe to enhance drug discovery research for better human health. This book demonstrates that various expertise are essential for drug discovery including synthetic or natural drugs, clinical pharmacology, receptor identification, drug metabolism, pharmacodynamic and pharmacokinetic research. The following 5 sections cover diverse chapter topics in drug discovery: Natural Products as Sources of Leading Molecules in Drug Discovery; Oncology and Drug Discovery; Receptors Involvement in Drug Discovery; Management and Development of Drugs against Infectious Diseases; Advanced Methodology.

Antibiotic Discovery and Development Book

Antibiotic Discovery and Development

  • Author : Thomas J. Dougherty
  • Publisher : Springer Science & Business Media
  • Release Date : 2011-12-18
  • Genre: Medical
  • Pages : 1127
  • ISBN 10 : 9781461414001

Antibiotic Discovery and Development Excerpt :

This volume covers all aspects of the antibiotic discovery and development process through Phase II/III. The contributors, a group of highly experienced individuals in both academics and industry, include chapters on the need for new antibiotic compounds, strategies for screening for new antibiotics, sources of novel synthetic and natural antibiotics, discovery phases of lead development and optimization, and candidate compound nominations into development. Beyond discovery , the handbook will cover all of the studies to prepare for IND submission: Phase I (safety and dose ranging), progression to Phase II (efficacy), and Phase III (capturing desired initial indications). This book walks the reader through all aspects of the process, which has never been done before in a single reference. With the rise of antibiotic resistance and the increasing view that a crisis may be looming in infectious diseases, there are strong signs of renewed emphasis in antibiotic research. The purpose of the handbook is to offer a detailed overview of all aspects of the problem posed by antibiotic discovery and development.

Antimicrobial Drug Resistance Book

Antimicrobial Drug Resistance

  • Author : Douglas L. Mayers
  • Publisher : Springer
  • Release Date : 2017-06-19
  • Genre: Medical
  • Pages : 773
  • ISBN 10 : 9783319467184

Antimicrobial Drug Resistance Excerpt :

The two volumes included in Antimicrobial Drug Resistance, Second Edition is an updated, comprehensive and multidisciplinary reference covering the area of antimicrobial drug resistance in bacteria, fungi, viruses, and parasites from basic science, clinical, and epidemiological perspectives. This newly revised compendium reviews the most current research and development on drug resistance while still providing the information in the accessible format of the first edition. The first volume, Antimicrobial Drug Resistance: Mechanisms of Drug Resistance, is dedicated to the biological basis of drug resistance and effective avenues for drug development. With the emergence of more drug-resistant organisms, the approach to dealing with the drug resistance problem must include the research of different aspects of the mechanisms of bacterial resistance and the dissemination of resistance genes as well as research utilizing new genomic information. These approaches will permit the design of novel strategies to develop new antibiotics and preserve the effectiveness of those currently available. The second volume, Antimicrobial Drug Resistance: Clinical and Epidemiological Aspects, is devoted to the clinical aspects of drug resistance. Although there is evidence that restricted use of a specific antibiotic can be followed by a decrease in drug resistance to that agent, drug resistance control is not easily achieved. Thus, the infectious diseases physician requires input from the clinical microbiologist, antimicrobial stewardship personnel, and infection control specialist to make informed choices for the effective management of various strains of drug-resistant pathogens in individual patients. This 2-volume set is an important reference for students in microbiology, infectious diseases physicians, medical students, basic scientists, drug development researchers, microbiologists, epidemiologists, and public health practitioners.

Antibacterial Agents Book

Antibacterial Agents

  • Author : Rosaleen Anderson
  • Publisher : John Wiley & Sons
  • Release Date : 2012-05-30
  • Genre: Science
  • Pages : 376
  • ISBN 10 : 9781118325445

Antibacterial Agents Excerpt :

Antibacterial agents act against bacterial infection either bykilling the bacterium or by arresting its growth. They do this bytargeting bacterial DNA and its associated processes, attackingbacterial metabolic processes including protein synthesis, orinterfering with bacterial cell wall synthesis and function. Antibacterial Agents is an essential guide to this importantclass of chemotherapeutic drugs. Compounds are organised accordingto their target, which helps the reader understand the mechanism ofaction of these drugs and how resistance can arise. The book usesan integrated “lab-to-clinic” approach which coversdrug discovery, source or synthesis, mode of action, mechanisms ofresistance, clinical aspects (including links to currentguidelines, significant drug interactions, cautions andcontraindications), prodrugs and future improvements. Agents covered include: agents targeting DNA - quinolone, rifamycin, and nitroimidazoleantibacterial agents agents targeting metabolic processes - sulfonamideantibacterial agents and trimethoprim agents targeting protein synthesis - aminoglycoside, macrolideand tetracycline antibiotics, chloramphenicol, andoxazolidinones agents targeting cell wall synthesis - β-Lactam andglycopeptide antibiotics, cycloserine, isonaizid, anddaptomycin Antibacterial Agents will find a place on the bookshelvesof students of pharmacy, pharmacology, pharmaceutical sciences,drug design/discovery, and medicinal chemistry, and as a benchreference for pharmacists and pharmaceutical researchers inacademia and industry.

The Resistance Phenomenon in Microbes and Infectious Disease Vectors Book

The Resistance Phenomenon in Microbes and Infectious Disease Vectors

  • Author : Institute of Medicine
  • Publisher : National Academies Press
  • Release Date : 2003-03-26
  • Genre: Medical
  • Pages : 333
  • ISBN 10 : 0309168309

The Resistance Phenomenon in Microbes and Infectious Disease Vectors Excerpt :

The resistance topic is timely given current events. The emergence of mysterious new diseases, such as SARS, and the looming threat of bioterrorist attacks remind us of how vulnerable we can be to infectious agents. With advances in medical technologies, we have tamed many former microbial foes, yet with few new antimicrobial agents and vaccines in the pipeline, and rapidly increasing drug resistance among infectious microbes, we teeter on the brink of loosing the upperhand in our ongoing struggle against these foes, old and new. The Resistance Phenomenon in Microbes and Infectious Disease Vectors examines our understanding of the relationships among microbes, disease vectors, and human hosts, and explores possible new strategies for meeting the challenge of resistance.

Antibiotics Book


  • Author : Claudio O. Gualerzi
  • Publisher : John Wiley & Sons
  • Release Date : 2013-09-05
  • Genre: Medical
  • Pages : 576
  • ISBN 10 : 9783527659708

Antibiotics Excerpt :

Most of the antibiotics now in use have been discovered more or less by chance, and their mechanisms of action have only been elucidated after their discovery. To meet the medical need for next-generation antibiotics, a more rational approach to antibiotic development is clearly needed. Opening with a general introduction about antimicrobial drugs, their targets and the problem of antibiotic resistance, this reference systematically covers currently known antibiotic classes, their molecular mechanisms and the targets on which they act. Novel targets such as cell signaling networks, riboswitches and bacterial chaperones are covered here, alongside the latest information on the molecular mechanisms of current blockbuster antibiotics. With its broad overview of current and future antibacterial drug development, this unique reference is essential reading for anyone involved in the development and therapeutic application of novel antibiotics.

Catching Breath Book
Score: 5
From 1 Ratings

Catching Breath

  • Author : Kathryn Lougheed
  • Publisher : Bloomsbury Publishing
  • Release Date : 2017-06-15
  • Genre: Science
  • Pages : 288
  • ISBN 10 : 9781472930361

Catching Breath Excerpt :

Tuberculosis is an ancient disease, but it's not a disease of history. With more than a million victims every year – more than any other disease, including malaria – and antibiotic resistance now found in every country worldwide, tuberculosis is once again proving itself to be one of the smartest killers humanity has ever faced. But it's hardly surprising considering how long it's had to hone its skills. Forty-thousand years ago, our ancestors set off from the cradle of civilisation on their journey towards populating the planet. Tuberculosis hitched a lift and came with us, and it's been there ever since; waiting, watching, and learning. In The Robber of Youth, Kathryn Lougheed, a former TB research scientist, tells the story of how tuberculosis and humanity have grown up together, with each being shaped by the other in more ways than you could imagine. This relationship between man and microbe has spanned many millennia and has left its mark on both species. We can see evidence of its constant shadow in our genes; in the bones of the ancient dead; in art, music and literature. Tuberculosis has shaped societies - and it continues to do so today. The organism responsible for TB, Mycobacterium tuberculosis, has had plenty of time to adapt to its chosen habitat – human lungs – and has learnt through natural selection to be an almost perfect pathogen. Using our own immune cells as a Trojan Horse to aid its spread, it's come up with clever ways to avoid being killed by antibiotics. But patience has been its biggest lesson - the bacterium can enter into a latent state when times are tough, only to come back to life when a host's immune system can no longer put up a fight. Today, more than one million people die of the disease every year and around one-third of the world's population are believed to be infected. That's more than two billion people. Throw in the compounding problems of drug resistance, the HIV epidemic and poverty, and it's clear that tuberculosis